By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Wednesday marked the last day of the UBS Global Life Sciences Conference where Affymetrix and Exiqon presented to investors.

Below are highlights from their talks.

Affymetrix

Nearing three months into his return trip to Affymetrix, CEO Frank Witney continued to stress piggybacking on the next-generation sequencing market as a strategy to revive the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.